Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss KYMR - Kymera Therapeutics, Inc.
-552 K
LAST VALUE
8.55%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR